IDEXX Labs (IDXX) Tops Q1 EPS by 11c ; Offers Guidance

IDEXX Labs (NASDAQ: IDXX) reported Q1 EPS of $2.81, $0.11 better than the analyst estimate of $2.70. Revenue for the quarter came in at $964.09 million versus the consensus estimate of $966.41 million.

GUIDANCE:

IDEXX Labs sees FY2024 EPS of $10.82-$11.20, versus the consensus of $11.14. IDEXX Labs sees FY2024 revenue of $3.89-3.96 billion, versus the consensus of $3.98 billion.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• IDEXX Laboratories (IDXX) PT Lowered to $710 at Barclays
• ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c